CD40L-expressing Adze-1.17.C

N/A

Report date: 2025/03/19 11:37:14

Base Information

Drug NameCD40L-expressing Adze-1.17.C
Drug Alias NameCD40L-expressing oncolytic virus therapy (Adze Biotechnology)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonists
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdze Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdze Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A